Vismodegib resistant mutations are not selected in multifocal relapses of locally advanced basal cell carcinoma after vismodegib discontinuation. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/jdv.15741
PubMed Identifier: 31187903
Publication URI: http://europepmc.org/abstract/MED/31187903
Type: Journal Article/Review
Volume: 33
Parent Publication: Journal of the European Academy of Dermatology and Venereology : JEADV
Issue: 11
ISSN: 0926-9959